We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

1 hedge funds and large institutions have $744 invested in Albireo Pharma Inc in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $756 → $744 (-$12)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$744 – – –

ALBO Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2023, worth a combined $744 — down 1.6% from $756 a quarter earlier.

Fund positioning in ALBO was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Albireo Pharma Inc (ALBO) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $744 of Albireo Pharma Inc stock for Q3 2023, down 1.6% quarter-over-quarter.
  • 0 funds opened new Albireo Pharma Inc positions in Q3 2023 and 0 closed out.

Based on aggregated 13F filings for Q3 2023.